A recent report by the European Parliament uses outdated and fragmented data on children exposed to second-hand smoke to support its resolution on non-communicable diseases. Companies with significant amounts of facts and data should be heard in order to gather all necessary evidence for public policy making.
There is widespread consensus, particularly within academic institutions and NGOs, that Reduced Risk Products (RRPs) contribute to Tobacco Harm Reduction (THR) JTI’s Chris Woods and Grant O’Connell debate the issue and explain how scientific evidence can help lead consumers to make their own decisions when considering a switch from traditional cigarettes to RRPs.
Recent unfounded allegations over the delay of the Commission’s recommendation on smoke-free environments re-iterate the need for transparency, accountability and inclusiveness on public policies.
JTI supports evidence-based, proportionate and effective regulation of tobacco products, but also strongly believes in its right to express its point of view as it relates to its products and the industry.
In February the World Health Organization (WHO) underpinned their reserved attitude towards alternative tobacco and nicotine products, continuing their general advocacy that regulators should treat them as equivalent to combustibles tobacco products (e.g. cigarettes).
However, a recent study by the Oxford Economics institute that pursuing a harsh stance towards RRP (heated tobacco products and e-cigarettes) could not only limit policymakers’ options for mitigating health risks but also put at risk the positive economic footprint supported by the RRP industry.
about “The economics of reduced-risk products – global policy landscape and principles for policy treatment”
Don’t miss out on these articles and studies from think tanks and academia which shed some light on lifestyle regulations and the need to consider the evolution happening in the industry.